1411
|
|
|
Cytochrome c oxidase subunit 7B |
APLCC, LSDMCA2 |
|
1412
|
|
|
Cytochrome c oxidase subunit 7B2 |
- |
|
1413
|
|
|
Cytochrome c oxidase subunit 7C |
- |
|
1414
|
|
|
Cytochrome c oxidase subunit 8A |
COX, COX8, COX8-2, COX8L, MC4DN15, VIII, VIII-L |
|
1415
|
|
|
Cytochrome c oxidase associated subunit FA4 |
CI-9k, CI-MLRQ, MC4DN21, MISTR1, MLRQ, MRCAF1, NDUFA4 |
|
1416
|
|
|
Cytochrome c oxidase hypoxia associated subunit FA4L2 |
MISTRH, NDUFA4L2, NUOMS |
|
1417
|
|
|
Ceruloplasmin |
AB073614, CP-2 |
Aceruloplasminemia, Experimental arthritis, Rheumatoid arthritis, Ataxia, Autism, Brain disease, Hepatocellular carcinoma, Colonic neoplasms, Ferroxidase deficiency, Dementia, Diabetes mellitus, Diabetes mellitus type 1, Disorder of iron metabolism and transport, Dyskinesia, Epilepsy, Apoceruloplasmin deficiency, Hemochromatosis, Hemosiderosis, Hepatitis, Hepatolenticular degeneration, Iron metabolism disorder, Iron overload, Kidney failure, Liver cirrhosis, Liver neoplasms, Melanoma, Neurodegeneration with brain iron accumulation, Parkinson disease, Preeclampsia, Psoriasis, Retinal degeneration, SchizophreniaView all (17 more) |
1418
|
|
|
Carboxypeptidase A1 |
CPA |
|
1419
|
|
|
Carboxypeptidase A2 |
- |
|
1420
|
|
|
Carboxypeptidase A3 |
MC-CPA |
|